怀俄明州夏延，2026 年 1 月 21 日（全球新闻稿）——CS Diagnostics Corp.（OTCQB：CSDX）今天详细介绍了其 多渠道销售策略、全球物流合作伙伴关系 和 可持续发展路线图，以支持 MEDUSA SDP 的商业推广。
<img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92/logo.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92/logo.png"/>
公司计划通过多样化的销售模式分销 MEDUSA SDP，以满足机构和消费者的需求。
B2B 分销渠道包括：
<ul>
<li>医院和医疗机构</li>
<li>健身房和健康中心</li>
<li>学校和教育机构</li>
<li>企业和工业客户</li>
</ul>
B2C 渠道包括：
<ul>
<li>在 阿联酋 和 德国 的实体零售店货架上。</li>
<li>在线市场，如 亚马逊、Noon 和领先的德国电子商务平台</li>
<li>通过官方 MEDUSA 电子商务网站 进行直接面向消费者的销售</li>
</ul>
<img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c/medusa-drink.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c/medusa-drink.png"/>
为了支持高效的全球履行，DHL 已被选为大宗和机构货物运输的承运商，而 FedEx 将负责零售和面向消费者的配送。
展望未来，公司预计将开始 生物可降解、可溶解的 MEDUSA SDP 湿巾系列 的监管审批流程，这代表了可持续卫生解决方案的突破性进展，并强化了 CSDX 的长期环境战略。
<img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/22a15a74-b111-4b35-8fca-b3f8252f17c1/medusa-wipes.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/22a15a74-b111-4b35-8fca-b3f8252f17c1/medusa-wipes.png"/>
“CS Group 专注于有序执行、战略合作伙伴关系和可扩展增长，” 管理层表示。“MEDUSA SDP 展示了我们如何将创新转化为商业上可行、全球相关的产品，同时推动可持续发展。”
关于 CS Diagnostics Corp
CS Diagnostics Corp.（OTCQB：CSDX）是一家医疗技术公司，推动感染控制和肿瘤学的双重重点平台，瞄准全球医疗保健市场的高优先级领域。公司的产品组合包括 MEDUSA，一个智能消毒剂和卫生解决方案平台，正在扩展到用于机构和消费者的湿巾和液体配方，以及 CS Protect-Hydrogel，一种在前列腺癌放疗期间保护健康器官的组织间隔器。CSDX 正在通过关键的商业化里程碑，包括战略制造合作伙伴关系、在海湾合作委员会和欧洲的多地区推出、多样化的 B2B 和 B2C 分销渠道、全球物流协议以及不断增长的知识产权和监管路线图。计划推出生物可降解、可溶解的卫生产品并扩展国际市场。
前瞻性声明
本公告包含与预期或预期未来事件和结果相关的前瞻性声明，这些声明具有前瞻性特征，因此受到某些风险和不确定性的影响，例如一般经济、市场和商业条件、合格员工的竞争、监管过程和行动、技术问题、新立法、由于潜在延误或计划变更而产生的不确定性、在新的政治管辖区工作所带来的不确定性、勘探结果的不确定性、勘探权的时机和授予的不确定性、监管和其他第三方同意及批准的时机和授予的不确定性、公司或任何第三方执行和实施未来计划的能力的不确定性，以及意外事件的发生。
实际结果可能因众多已知和未知的风险、不确定性和其他因素而与此处提供的信息有所不同。
欲了解更多信息，请访问 https://medusa-sdp.com/en/
或联系
Mohammad Essayed
电子邮件：info@csdcorp.us
随本公告附带的照片可在以下网址获取：
https://www.globenewswire.com/NewsRoom/AttachmentNg/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92
https://www.globenewswire.com/NewsRoom/AttachmentNg/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c
https://www.globenewswire.com/NewsRoom/AttachmentNg/22a15a74-b111-4b35-8fca-b3f8252f17c1
<img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU9UYzRNaU0zTXpjek1EazBJelV3TURFMU56VXlNZz09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU9UYzRNaU0zTXpjek1EazBJelV3TURFMU56VXlNZz09"/>
<img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/OGFlZjc2YWUtMDM5Ni00ZTlhLWFlZjAtZDIyZmJhZDQ0NzFjLTUwMDE1NzUyMi0yMDI2LTAxLTIxLWVu/tiny/CS-Diagnostics-Corp-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/OGFlZjc2YWUtMDM5Ni00ZTlhLWFlZjAtZDIyZmJhZDQ0NzFjLTUwMDE1NzUyMi0yMDI2LTAxLTIxLWVu/tiny/CS-Diagnostics-Corp-.png"/>

CS Diagnostics Corp.（OTCQB：CSDX）宣布了一项针对其 MEDUSA SDP 产品的多渠道销售策略，目标是机构市场和消费者市场。该公司将与 DHL 和 FedEx 合作，利用其全球物流网络。此外，CSDX 计划推出可生物降解的湿巾，作为其可持续发展路线图的一部分。管理层强调通过严格执行和战略合作伙伴关系来推动医疗保健领域的增长和创新

CHEYENNE, Wyo., Jan. 21, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) today detailed its multi-channel sales strategy, global logistics partnerships, and sustainability roadmap supporting the commercial rollout of MEDUSA SDP.
<div class="lb-trans">怀俄明州夏延，2026 年 1 月 21 日（全球新闻稿）——CS Diagnostics Corp.（OTCQB：CSDX）今天详细介绍了其 多渠道销售策略、全球物流合作伙伴关系 和 可持续发展路线图，以支持 MEDUSA SDP 的商业推广。
</div><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92/logo.png" alt="" original-src="https://ml.globenewswire.com/Resource/Download/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92/logo.png"/>
The Company plans to distribute MEDUSA SDP through a diversified sales model designed to serve both institutional and consumer demand.
<div class="lb-trans">公司计划通过多样化的销售模式分销 MEDUSA SDP，以满足机构和消费者的需求。
</div>B2B distribution channels include:
<div class="lb-trans">B2B 分销渠道包括：
</div><ul>
<li>Hospitals and healthcare facilities</li>
<li>Gyms and wellness centers</li>
<li>Schools and educational institutions</li>
<li>Corporate and industrial clients</li>
</ul>
<div class="lb-trans"><ul>
<li>医院和医疗机构</li>
<li>健身房和健康中心</li>
<li>学校和教育机构</li>
<li>企业和工业客户</li>
</ul>
</div>B2C channels include:
<div class="lb-trans">B2C 渠道包括：
</div><ul>
<li>Physical retail Stores shelves, in UAE and Germany.</li>
<li>Online marketplaces such as Amazon, Noon, and leading German e-commerce platforms</li>
<li>Direct-to-consumer sales via the official MEDUSA e-commerce website</li>
</ul>
<div class="lb-trans"><ul>
<li>在 阿联酋 和 德国 的实体零售店货架上。</li>
<li>在线市场，如 亚马逊、Noon 和领先的德国电子商务平台</li>
<li>通过官方 MEDUSA 电子商务网站 进行直接面向消费者的销售</li>
</ul>
</div><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c/medusa-drink.png" alt="" original-src="https://ml.globenewswire.com/Resource/Download/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c/medusa-drink.png"/>
<div class="lb-trans"><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c/medusa-drink.png" alt="" original-src="https://ml.globenewswire.com/Resource/Download/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c/medusa-drink.png"/>
</div>To support efficient global fulfillment, DHL has been selected for bulk and institutional shipments, while FedEx will manage retail and consumer-focused deliveries.
<div class="lb-trans">为了支持高效的全球履行，DHL 已被选为大宗和机构货物运输的承运商，而 FedEx 将负责零售和面向消费者的配送。
</div>Looking ahead, the Company expects to begin regulatory approval processes for a bio-degradable, dissolving MEDUSA SDP wet wipes line, representing a breakthrough advancement in sustainable hygiene solutions and reinforcing CSDX’s long-term environmental strategy.
<div class="lb-trans">展望未来，公司预计将开始 生物可降解、可溶解的 MEDUSA SDP 湿巾系列 的监管审批流程，这代表了可持续卫生解决方案的突破性进展，并强化了 CSDX 的长期环境战略。
</div><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/22a15a74-b111-4b35-8fca-b3f8252f17c1/medusa-wipes.png" alt="" original-src="https://ml.globenewswire.com/Resource/Download/22a15a74-b111-4b35-8fca-b3f8252f17c1/medusa-wipes.png"/>
“CS Group is focused on disciplined execution, strategic partnerships, and scalable growth,” Management stated. “MEDUSA SDP demonstrates how we translate innovation into commercially viable, globally relevant products while advancing sustainability.”
<div class="lb-trans">“CS Group 专注于有序执行、战略合作伙伴关系和可扩展增长，” 管理层表示。“MEDUSA SDP 展示了我们如何将创新转化为商业上可行、全球相关的产品，同时推动可持续发展。”
</div>About CS Diagnostics Corp
<div class="lb-trans">关于 CS Diagnostics Corp
</div>CS Diagnostics Corp. (OTCQB: CSDX) is a medical technology company advancing a dual-focus platform across infection control and oncology, targeting high-priority global healthcare markets. The Company’s portfolio includes MEDUSA, a smart disinfectant and hygiene solutions platform expanding into wet wipes and liquid formulations for institutional and consumer use, and CS Protect-Hydrogel, a tissue spacer designed to protect healthy organs during prostate cancer radiotherapy. CSDX is progressing through key commercialization milestones, including strategic manufacturing partnerships, a multi-region launches across the GCC and Europe, diversified B2B and B2C distribution channels, global logistics agreements, and a growing intellectual property and regulatory roadmap. With plans to introduce biodegradable, dissolving hygiene products and expand internationally.
<div class="lb-trans">CS Diagnostics Corp.（OTCQB：CSDX）是一家医疗技术公司，推动感染控制和肿瘤学的双重重点平台，瞄准全球医疗保健市场的高优先级领域。公司的产品组合包括 MEDUSA，一个智能消毒剂和卫生解决方案平台，正在扩展到用于机构和消费者的湿巾和液体配方，以及 CS Protect-Hydrogel，一种在前列腺癌放疗期间保护健康器官的组织间隔器。CSDX 正在通过关键的商业化里程碑，包括战略制造合作伙伴关系、在海湾合作委员会和欧洲的多地区推出、多样化的 B2B 和 B2C 分销渠道、全球物流协议以及不断增长的知识产权和监管路线图。计划推出生物可降解、可溶解的卫生产品并扩展国际市场。
</div>Forward-Looking Statements
<div class="lb-trans">前瞻性声明
</div>This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the timing and granting of regulatory and other third party consents and approvals, uncertainties regarding the Company's or any third party's ability to execute and implement future plans, and the occurrence of unexpected events.
<div class="lb-trans">本公告包含与预期或预期未来事件和结果相关的前瞻性声明，这些声明具有前瞻性特征，因此受到某些风险和不确定性的影响，例如一般经济、市场和商业条件、合格员工的竞争、监管过程和行动、技术问题、新立法、由于潜在延误或计划变更而产生的不确定性、在新的政治管辖区工作所带来的不确定性、勘探结果的不确定性、勘探权的时机和授予的不确定性、监管和其他第三方同意及批准的时机和授予的不确定性、公司或任何第三方执行和实施未来计划的能力的不确定性，以及意外事件的发生。
</div>Actual results achieved may vary from the information provided herein because of numerous known and unknown risks, uncertainties, and other factors.
<div class="lb-trans">实际结果可能因众多已知和未知的风险、不确定性和其他因素而与此处提供的信息有所不同。
</div>For further information, please visit https://medusa-sdp.com/en/
<div class="lb-trans">欲了解更多信息，请访问 https://medusa-sdp.com/en/
</div>or contact
<div class="lb-trans">或联系
</div>Mohammad Essayed
<div class="lb-trans">Mohammad Essayed
</div>Email: info@csdcorp.us
<div class="lb-trans">电子邮件：info@csdcorp.us
</div>Photos accompanying this announcement are available at:
<div class="lb-trans">随本公告附带的照片可在以下网址获取：
</div>https://www.globenewswire.com/NewsRoom/AttachmentNg/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92
<div class="lb-trans">https://www.globenewswire.com/NewsRoom/AttachmentNg/41a98fdf-ea7e-43e7-bc45-d5ba415c9a92
</div>https://www.globenewswire.com/NewsRoom/AttachmentNg/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c
<div class="lb-trans">https://www.globenewswire.com/NewsRoom/AttachmentNg/dd6a88b8-aad6-4327-b9bf-47c89ed48a1c
</div>https://www.globenewswire.com/NewsRoom/AttachmentNg/22a15a74-b111-4b35-8fca-b3f8252f17c1
<div class="lb-trans">https://www.globenewswire.com/NewsRoom/AttachmentNg/22a15a74-b111-4b35-8fca-b3f8252f17c1
</div><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU9UYzRNaU0zTXpjek1EazBJelV3TURFMU56VXlNZz09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYyOTc4MiM3MzczMDk0IzUwMDE1NzUyMg=="/>
<img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/OGFlZjc2YWUtMDM5Ni00ZTlhLWFlZjAtZDIyZmJhZDQ0NzFjLTUwMDE1NzUyMi0yMDI2LTAxLTIxLWVu/tiny/CS-Diagnostics-Corp-.png" alt="" original-src="https://ml.globenewswire.com/media/OGFlZjc2YWUtMDM5Ni00ZTlhLWFlZjAtZDIyZmJhZDQ0NzFjLTUwMDE1NzUyMi0yMDI2LTAxLTIxLWVu/tiny/CS-Diagnostics-Corp-.png"/>

CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP | CSDX Stock News

StockTitan

Cardio Diagnostics

基因改革 ETF - ARK

医疗业 ETF - SPDR

美国医疗保健供应商 ETF - iShares

标普健康医疗设备 ETF - SPDR

标普生物技术 ETF - SPDR

动态生物技术与基因组 ETF - Invesco

医药突破 ETF - ALPS

纽交所高增长板生物技术指数 ETF - First Trust

2 倍做多纳斯达克生物技术 ETF - ProShares

生物科技 ETF - VanEck Vectors

基因免疫&健康关怀 ETF - iShares

CARDIO DIAGNOSTICS HOLDINGS INC C/WTS (10/25/2027) TO PUR COM

美国医药设备 ETF - iShares

纳斯达克生物科技指数 ETF - iShares Nasdaq

CS Group (OTCQB: CSDX) 宣布了关于 MEDUSA SDP 的多渠道销售模式、全球物流合作伙伴以及可持续创新路线图 | CSDX 股票新闻